R
Power Law company profile
RAPT Therapeutics
Biotech & Life Sciences · San Francisco, United States · Founded 2015 · IPO 2019 Unicorn
Valuation
$1.53B
Market cap · Mar/2026
Global footprint
Where RAPT Therapeutics has talent and traffic
Web traffic by country
16K
monthly visits
across markets
across markets
🇺🇸 United States36.3%
🇨🇦 Canada21.3%
🇬🇧 United Kingdom20.6%
🇮🇳 India18.8%
🇫🇷 France1.9%
Patent intelligence
$23M patent portfolio · 19 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$23M
1.5% of market cap · 33.9× smaller than top peer BioNTech ($780M)
19 active patent families
Where RAPT Therapeutics innovates
Molecular biologyCCR4BiochemistryCell biologyImmunology
Above peer median on Legal
Quality vs same-sector peers
RAPT Therapeutics on the five Patsnap quality dimensions
RAPT Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where RAPT Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across RAPT Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee RAPT Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.